News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO


1/21/2009 6:36:45 AM

CORK, Ireland--(BUSINESS WIRE)--The KineMatik™ Group LTD (“KineMatik”), providers of software solutions for managing scientific R&D knowledge, information and processes, announced that it has appointed Michael G. Jarjour as President & CEO.

Mr. Jarjour, with more than eighteen years of experience in the pharmaceutical research and healthcare technology industries, will lead KineMatik as the company continues to offer leadership and innovation to its pharmaceutical, biotechnology and government clients.

“We are delighted to welcome Michael to the KineMatik team. His extensive experience in sales, marketing, operations and strategic planning, combined with his background and entrepreneurial skills in the life sciences and technology industries, will help us consolidate our position as leaders in the scientific enterprise content of management space,” said Harry Lorton, Chairman of the Board of Directors for KineMatik.

“I am pleased to join KineMatik, which has developed an impressive and innovative technology platform,” said Mr. Jarjour. “Serving industries so dependent on the rapid, accurate collection of scientific data, KineMatik offers a unique value proposition by supporting secure portfolio, knowledge and project management while lowering costs, increasing productivity and improving time-to-market. In this era of financial and regulatory scrutiny, and intellectual property protection, KineMatik is poised to make a difference in the research and development process.”

Before joining KineMatik, Mr. Jarjour was Vice President of Global Marketing for Organon, responsible for leading the $1.5 billion gynecology and urology franchise.

Previously, Mr. Jarjour held key positions at top tier pharmaceutical organizations including Bristol-Myers Squibb, Pharmacia, Warner Lambert and Wyeth. Prior to his work in the pharmaceutical industry, he was the COO and founder of a healthcare technology enterprise for an award-winning, best-in-industry wireless Internet prescribing platform.

Mr. Jarjour holds a BS in Finance from Florida International University and an MBA from the Rutgers University.

About KineMatik:

KineMatik brings business methods to the life sciences R&D process, by increasing productivity, accountability and transparency. The company’s flagship product, eNovator, is the only software program that lets pharmaceutical, biotechnology and government organizations collaboratively manage their information, knowledge and business processes in one seamlessly integrated and secure system. eNovator, allows researchers to deliver innovation throughout the R&D product development lifecycle. Established in Cork, Ireland in 1999, KineMatik also has offices in London, Princeton, and San Diego. Additional information is available at www.kinematik.com.

Contact:

KineMatik Jennifer Buchholz, 215-840-9252 jbuchholz@kinematik.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES